ZANZALINTINIB

UNII:	KC2JC2ZA04
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₉H₂₅FN₄O₅
Preferred Substance Name:	ZANZALINTINIB
InChIKey:	JSPCKALGNNVYOO-UHFFFAOYSA-N
GSRS Full Record:	KC2JC2ZA04 i

2367004-54-2
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N′-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
1-N'-(4-fluorophenyl)-1-N-[4-[7-methoxy-6-(methylcarbamoyl)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide
N-(4-fluorophenyl)-N'-(4-{[7-methoxy-6- (methylcarbamoyl)quinolin-4- yl]oxy}phenyl)cyclopropane-1,1-dicarboxamide
XL-092
XL092
ZANZALINTINIB [USAN]
Zanzalintinib
Zanzalintinib [WHO-DD]
zanzalintinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZANZALINTINIB

Synonyms and Mappings

Resources